Cover Image
Market Research Report

Global Life Science Analytics Market - Segmented by Product Type, Application, End User and Geography - Growth, Trends, and Forecast (2018 - 2023)

Published by Mordor Intelligence LLP Product code 708576
Published Content info 115 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Life Science Analytics Market - Segmented by Product Type, Application, End User and Geography - Growth, Trends, and Forecast (2018 - 2023)
Published: September 1, 2018 Content info: 115 Pages
Description

The global Life Science analytics market is expected to register a CAGR of nearly 12.5 % during the forecast period, 2018-2023. The application of analytics has emerged as a useful tool for numerous pharmaceutical, medical device and biotechnological enterprises, as these choices help to overcome challenges in data integration and enhance operational efficiency. The key applications of analytics in pharmaceutical and life sciences include regulatory compliance reporting, marketing and product or service enablement.

Increasing Adoption of Analytics Solutions in Pharmaceuticals and Clinical Trials

There is a rise in use of analytics in clinical trials as the clinical trials conduction has become a complex process where it involves many activities and generates high volumes of data from different systems. With changing regulatory protocol requirements for clinical trial conduction and challenge in data collection, analyzing and report preparation for quick submission to health authority, hence the use of analytics in clinical trials is rising.

Analytics will help in optimizing the drug discovery and improve the efficiency of clinical trials. With huge data generated from Research & Development process and clinical research, the pharma companies can identify potential drug candidates with high probability of successfully developing in to drugs. Most contract research organizations (CROs) with established systems for Data capture, advanced analytics are now incorporated across all systems such as drug discovery, clinical development and CRO's which is providing real time analysis and creating alerts to each divisions concerning safety or efficacy. Application of analytics in evaluating a potential drug candidate for clinical development may reduce the time and R&D expenditure. Eli Lilly's has developed Phenotypic Drug Discovery Platform, where researchers can screen their compounds without giving intellectual property. The importance of Real-time analysis has become more important to pharmaceutical companies as payers impose value-based pricing, health authorities offering incentives for health outcomes. Some companies are in creating networks to collect, analyze, share and respond to queries on health outcomes.

Other factors that drive this market include advancements in technology, and growing pressure to reduce healthcare spending.

High Implementation Costs

Life science companies that include Pharma, contract research organization (CRO) and others face increasing pressure to allocate budget in establishing infrastructure for analytics division. Many companies in the past never had a clear understanding about the role of analytics in Pharma or clinical trials. Those companies that recognized the importance of analytics have established their own in house analytics department or outsourced to third party their requirement.

Costs increase sometimes if a company they have bought a subscription based analytical tool for their business and after a period of time realize that the selected analytical tool doesn't meet their business needs. All the costs associated with installation and implementation processes are lost investment for the company. Major companies like Pfizer with deep pockets to invest already have their own Real World Data and Analytics centers and applying those analytics-generated insights to deliver personalized care services. Mid-size and small companies pose high cost for partnering with established analytics companies to explore their strategy for business development opportunities. Hence, high implementation costs are restraining the growth of life science analytics market.

Other factor impeding this market include lack of skilled personnel.

US dominates the North American Region For Life Science Analytics Market

The US accounts for the largest share in the North America region for the market studied. This can be primarily attributed to presence of more number of pharmaceutical companies and even more number of clinical trials are occurring in this region, which are expected to augment the growth of the market studied over the forecast period.

Key Developments in the Life Science Analytics Market:

  • May 2018: Sanofi Chooses Accenture Interactive to Create UWell's Healthcare Platform to Better Serve Consumers.
  • Major Players: ORACLE CORPORATION, QUINTILES, INC., SAS INSTITUTE INC., IBM CORPORATION, MAXISIT, SCIO HEALTH ANALYTICS, TAKE SOLUTIONS, WIPRO LIMITED, ACCENTURE, COGNIZANT, among others.

Reasons to Purchase Life Science Analytics Market Report:

  • Current and future of Life Science analytics market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter's five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of Life Science Analytics Market Report:

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs

Table of Contents
Product Code: 62770

Table of Contents

1. Introduction

  • 1.1. Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Life Science Analytics Market Overview

  • 5.1. Current Market Scenario
  • 5.2. Porter's Five Forces Analysis
    • 5.2.1. Bargaining Power of Suppliers
    • 5.2.2. Bargaining Power of Consumers
    • 5.2.3. Threat of New Entrants
    • 5.2.4. Threat of Substitute Product and Services
    • 5.2.5. Degree of Competition

6. Life Science Analytics Market Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

  • 6.1. Life Science Analytics Market Drivers
    • 6.1.1. Advancements in Technology
    • 6.1.2. Increasing Adoption of Analytics Solutions in Pharmaceuticals and Clinical Trials
    • 6.1.3. Growing Pressure to Reduce Healthcare Spending and the Need for Improved Patient Outcomes
  • 6.2. Life Science Analytics Market Restraints
    • 6.2.1. Lack of Skilled Personnel
    • 6.2.2. High Implementation Costs
  • 6.3. Opportunities
  • 6.4. Challenges

7. Life Science Analytics Market Segmentation

  • 7.1. By Product Type
    • 7.1.1. Descriptive Analytics
    • 7.1.2. Predictive Analytics
    • 7.1.3. Prescriptive Analytics
  • 7.2. By Application
    • 7.2.1. Research and Development
    • 7.2.2. Supply Chain Analytics
    • 7.2.3. Sales and Marketing
    • 7.2.4. Pharmacovigilance
  • 7.3. By End User
    • 7.3.1. Clinical Research Institutions
    • 7.3.2. Pharmaceutical and Biotechnology Companies
    • 7.3.3. Medical Device Companies
    • 7.3.4. Others (Third-Party Administrators)
  • 7.4. By Geography
    • 7.4.1. North America Life Science Analytics Market Size (2018-2023)
      • 7.4.1.1. United states Life Science Analytics Market Size (2018-2023)
      • 7.4.1.2. Canada Life Science Analytics Market Size (2018-2023)
      • 7.4.1.3. Mexico Life Science Analytics Market Size (2018-2023)
    • 7.4.2. Europe Life Science Analytics Market Size (2018-2023)
      • 7.4.2.1. France Life Science Analytics Market Size (2018-2023)
      • 7.4.2.2. United kingdom Life Science Analytics Market Size (2018-2023)
      • 7.4.2.3. Germany Life Science Analytics Market Size (2018-2023)
      • 7.4.2.4. Spain Life Science Analytics Market Size (2018-2023)
      • 7.4.2.5. Italy Life Science Analytics Market Size (2018-2023)
      • 7.4.2.6. Rest of Europe
    • 7.4.3. Asia-Pacific Life Science Analytics Market Size (2018-2023)
      • 7.4.3.1. India Life Science Analytics Market Size (2018-2023)
      • 7.4.3.2. China Life Science Analytics Market Size (2018-2023)
      • 7.4.3.3. Japan Life Science Analytics Market Size (2018-2023)
      • 7.4.3.4. Australia Life Science Analytics Market Size (2018-2023)
      • 7.4.3.5. South Korea Life Science Analytics Market Size (2018-2023)
      • 7.4.3.6. Rest of Asia-Pacific
    • 7.4.4. South America Life Science Analytics Market Size (2018-2023)
      • 7.4.4.1. Brazil Life Science Analytics Market Size (2018-2023)
      • 7.4.4.2. Argentina Life Science Analytics Market Size (2018-2023)
      • 7.4.4.3. Rest of South America
    • 7.4.5. Middle East Africa Life Science Analytics Market Size (2018-2023)
      • 7.4.5.1. GCC Life Science Analytics Market Size (2018-2023)
      • 7.4.5.2. South Africa Life Science Analytics Market Size (2018-2023)
      • 7.4.5.3. Rest of Middle East & Africa

8. Competitive Landscape

  • 8.1. Mergers & Acquisition Analysis
  • 8.2. Agreements, Collaborations, and Partnerships
  • 8.3. New Products Launches

9. Key Players

  • 9.1. Oracle Corporation
  • 9.2. Quintiles, Inc.
  • 9.3. SAS Institute Inc.
  • 9.4. IBM Corporation
  • 9.5. Maxisit
  • 9.6. Scio Health Analytics
  • 9.7. Take Solutions
  • 9.8. Wipro Limited
  • 9.9. Accenture
  • 9.10. Cognizant

List not Exhaustive

10. Future of the Market

Back to Top